GB Sciences, Inc. (GBLX)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Oct 17, 2024, 4:00 PM EDT
GB Sciences Statistics
Total Valuation
GB Sciences has a market cap or net worth of 4,071. The enterprise value is 1.75 million.
Market Cap | 4,071 |
Enterprise Value | 1.75M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GB Sciences has 407.07 million shares outstanding. The number of shares has increased by 10.90% in one year.
Shares Outstanding | 407.07M |
Shares Change (YoY) | +10.90% |
Shares Change (QoQ) | +0.70% |
Owned by Insiders (%) | 6.89% |
Owned by Institutions (%) | n/a |
Float | 379.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.07 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -389.60% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -819,996 |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.95% in the last 52 weeks. The beta is 0.47, so GB Sciences's price volatility has been lower than the market average.
Beta (5Y) | 0.47 |
52-Week Price Change | +21.95% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 33.67 |
Average Volume (20 Days) | 64,707 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.42M |
Pretax Income | -1.36M |
Net Income | -1.64M |
EBITDA | -1.42M |
EBIT | -1.42M |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 11,991 in cash and 1.76 million in debt, giving a net cash position of -1.75 million or -0.00 per share.
Cash & Cash Equivalents | 11,991 |
Total Debt | 1.76M |
Net Cash | -1.75M |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -5.31M |
Book Value Per Share | -0.01 |
Working Capital | -4.99M |
Cash Flow
Operating Cash Flow | -975,698 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GB Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.90% |
Shareholder Yield | -10.90% |
Earnings Yield | -41,330.00% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |